EUTOS- European Treatment Outcome Study

Through the European Treatment and Outcome Study for CML programme, the European LeukemiaNet Novartis and are pleased to offer plasma imatinib monitoring free of charge (for sample transportation and dosing).

The pharmacological monitoring project has been designed to help physicians optimise treatment with imatinib.